BIOMARIN PHARMACEUTICAL INC Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $2.21 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-26
- BIOMARIN PHARMACEUTICAL INC unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $2.21M, a 2041.75% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $103.00K.
- BIOMARIN PHARMACEUTICAL INC unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $786.00K.
- BIOMARIN PHARMACEUTICAL INC unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2016 was $497.00K, a 65.82% decline from fiscal 2015.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month as first filed |
|---|---|---|
| 2025-12-31 | $2.21M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $103.00K 10-K · filed 2026-02-26 | |
| 2021-12-31 | $786.00K 10-K · filed 2023-02-27 | |
| 2016-12-31 | $497.00K 10-K · filed 2017-02-27 | |
| 2015-12-31 | $1.45M 10-K · filed 2017-02-27 | |
| 2014-12-31 | $545.00K 10-K · filed 2016-02-29 | -$545.00K 10-K · filed 2015-03-02 |
| 2013-12-31 | $194.00K 10-K · filed 2015-03-02 | |
| 2012-12-31 | $9.00K 10-K · filed 2014-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |